Sanofi India LimitedSANOFICorporate

Pharmaceuticals - Multinational Latest results: Jun 2026 12 quarters of data

₹2,942.10

MCap ₹6,776 Cr · P/E 20.9

Sanofi India Limited — Stock analysis & AI research Sanofi India Limited — Seasonality — best & worst months Sanofi India Limited — Technical indicators & charts Sanofi India Limited — Technical setup — score, trend, support & resistance Sanofi India Limited — Descending Channel pattern forming Sanofi India Limited — Live exchange announcements

📋 High Operating Margin Stocks 📋 High Interest Coverage Stocks 📈 Multi-Timeframe Bearish Stocks 📈 Stocks Near 52-Week Low 🏭 Pharma sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹438 Cr

Sales · Jun 2026

+7.8% YoY

₹115 Cr

Operating Profit · Jun 2026

+21.4% YoY

26.3%

OPM % · Jun 2026

+12.4% YoY

₹84 Cr

Net Profit · Jun 2026

+19.3% YoY

₹36.26

EPS · Jun 2026

+20.0% YoY

📝 Sanofi India Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Sanofi India Limited reported revenue of ₹438 crore for the quarter ended June 2026 (Q1 FY27), up 7.8% from ₹406 crore in the same quarter last year, and down 7.3% sequentially over the March 2026 quarter.

Net profit rose 19.3% year-on-year to ₹84 crore, from ₹70 crore. Earnings per share (EPS) came in at ₹36.26.

Operating profit stood at ₹115 crore — an operating margin (OPM) of 26.3%, compared with 23.4% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Sanofi India Limited posted revenue of ₹1,773 crore, a growth of 16.4% over FY25, with a net profit of ₹311 crore (up 1.8% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,805 crore with a net profit of ₹324 crore.

Valuation snapshot

At the current price of ₹2,942.10, SANOFI has a market capitalisation of ₹6,776 crore and a trailing P/E of about 20.9.

Within the Pharmaceuticals - Multinational industry, it is the 3rd-largest of the 3 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 60.40%, foreign institutional investors (FIIs) 5.69%, domestic institutional investors (DIIs) 19.87%, public shareholders 14.04% of Sanofi India Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹6,776 Cr

Current Price ?

₹2,942.1

P/E ?

20.88below ind

Industry P/E ?

24.10

P/B ?

N/A

P/S ?

3.75

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

4.8%

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

₹1,805 Cr

OPM ?

26.7%

Profit after tax (TTM) ?

₹324 Cr

EPS (TTM) ?

₹140.90

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹438 Cr

PAT — latest qtr ?

₹84 Cr

YoY qtr sales growth ?

7.8%

YoY qtr profit growth ?

19.3%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

N/A

Debt to Equity ?

N/A

Interest Coverage ?

425.0

Current Ratio ?

N/A

Ownership

Promoter holding ?

60.40%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

-13.8%

Return 6 months ?

-17.4%

🗓️ Quarterly results (12 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	706	715	694	511	464	524	536	406	475	420	472	438	+7.8%	-7.3%
Operating Profit	178	208	187	137	116	120	162	95	134	90	143	115	+21.4%	-19.4%
Other Income	16	12	12	41	5	2	3	9	-22	3	4	6	-31.1%	+55.0%
Interest	1	0	0	0	0	0	0	0	0	1	0	0	—	—
Depreciation	10	10	10	9	9	9	10	9	9	10	9	9	-1.1%	-1.1%
Profit Before Tax	183	210	189	169	139	113	165	94	102	83	138	112	+19.5%	-18.6%
Net Profit	123	152	138	137	103	82	120	70	76	62	103	84	+19.3%	-18.9%
EPS	53.37	66.08	59.79	59.39	44.90	35.69	51.96	30.22	33.04	26.83	44.61	36.26	+20.0%	-18.7%
OPM %	25.2%	29.2%	27.0%	26.8%	25.0%	22.8%	30.2%	23.4%	28.2%	21.4%	30.3%	26.3%	+12.4%	-13.2%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹1,524 Cr	₹1,773 Cr	₹1,805 Cr	+16.4%
Operating Profit	₹397 Cr	₹462 Cr	₹482 Cr	+16.3%
OPM %	26.08%	26.06%	26.72%	-0.1%
NPM %	20.06%	17.54%	17.98%	-12.6%
Other Income	₹10 Cr	₹-6 Cr	₹-9 Cr	-159.4%
Depreciation	₹28 Cr	₹37 Cr	₹37 Cr	+32.1%
Interest	₹1 Cr	₹1 Cr	₹1 Cr	+25.0%
EBIT	₹369 Cr	₹425 Cr	₹445 Cr	+15.1%
PBT	₹417 Cr	₹417 Cr	₹435 Cr	+0.0%
Tax	₹66 Cr	—	₹29 Cr	—
Net Profit	₹306 Cr	₹311 Cr	₹324 Cr	+1.8%
EPS	₹132.55	₹134.70	₹140.74	+1.6%
Material Cost	₹470 Cr	—	₹216 Cr	—
Employee Cost	₹117 Cr	—	₹45 Cr	—
Extraordinary Items	₹-19 Cr	—	—	—

👥 Shareholding (latest 1 periods)

Metric	Jun 2026	% Chg
Promoters	60.40%	—
FIIs	5.69%	—
DIIs	19.87%	—
Public	14.04%	—
No. of Shareholders	80,005	—

⚖️ Peer comparison

Industry: Pharmaceuticals - Multinational · 3 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	PGHL Procter & Gamble	₹5,321.00	8,833	24.7	1,433	358	32.5%	25.0%	15.6%	30.8%	7.3%	45.7%
2	SANOFICONR Sanofi Consumer	₹3,650.00	8,418	31.6	950	266	37.2%	28.0%	—	—	6.7%	12.8%
3	SANOFI Sanofi India	₹2,928.60	6,745	20.8	1,805	324	26.7%	18.0%	16.4%	1.8%	7.8%	19.3%

❓ Frequently asked questions

What was Sanofi India Limited's revenue in Q1 FY27?

What was Sanofi India Limited's net profit in Q1 FY27?